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Abstract
Introduction Degenerative cervical myelopathy (DCM) is a progressive neurodegenerative disorder. DCM is common (estimat-
ed prevalence, 2% of adults) and significantly impacts quality of life. The AO Spine RECODE-DCM (Research Objectives and
CommonData Elements in DCM) project has recently established the top research priorities for DCM. This article examines the
extent to which existing research activity aligns with the established research priorities.
Methods A systematic review ofMEDLINE and Embase for “Cervical”AND “Myelopathy”was conducted following PRISMA
guidelines. Full-text papers in English, exclusively studying DCM, published between January 1, 1995 and August 08, 2020
were considered eligible. Extracted data for each study included authors, journal, year of publication, location, sample size and
study design. Each study was then analysed for alignment to the established research priorities.
Results In total, 2261 papers with a total of 1,323,979 patients were included. Japan published more papers (625) than any other
country. Moreover, 2005 (89%) of 2261 papers were aligned to at least one research priority. The alignment of papers to the
different research priorities was unequal, with 1060 papers on themost researched priority alone (#15, predictors of outcome after
treatment), but only 64 total papers on the least-researched 10 priorities. The comparative growth of research in the different
priorities was also unequal, with some priorities growing and others plateauing over the past 5 years.
Discussion Research activity in DCM continues to grow, and the focus of this research remains on surgery. The established
research priorities therefore represent a new direction for the field.
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Introduction
Degenerative cervical myelopathy (DCM) is a progressive
neurological condition defined by symptomatic spinal cord
compression caused by arthritic narrowing of the spinal canal
[4]. It is common, estimated to affect as many as 2% of adults
[10], and has a significant impact on health-related quality of
life [9].
The AO Spine RECODE-DCM (Research Objectives and
Common Data Elements in DCM) project is an international
collaboration, supported by the AO Spine Foundation and
Myelopathy.org, which aims to accelerate knowledge
discovery in DCM, through a number of consensus
initiatives, including a James Lind Alliance priority setting
process to establish the top research priorities for DCM
(Table 1). Research priorities were selected through consensus
from a longlist of 74 unanswered research questions. The
longlist was formed by first consolidating 3404 research sug-
gestions, from an international and multi-disciplinary commu-
nity into unique research questions, and second checking cur-
rent evidence to ensure these are unanswered (aospine.org/
recode).
In order for this prioritisation process to have its desired
effect, the priorities must be adopted by the research commu-
nity. Therefore, a next stage of the project involves promoting
their uptake. This process, known often as knowledge transla-
tion (KT), is critical in bridging the gap between the acquisition
of knowledge (in this case, the research priorities) and the im-
plementation of this knowledge into practice (ensuring that
future research is aligned with the priorities).
This article is part of the Topical Collection on Spine degenerative
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The first step in the KT process is to establish a baseline to
define the gap that needs to be bridged and a reference point
for which KT interventions can be measured against. This
article therefore aims to establish the extent to which existing
Table 1 Top 26 priorities for DCM research. Priorities are listed in descending order of established importance. Each priority has a unique single-letter




1 What strategies can increase awareness and understanding of DCM amongst healthcare professionals and the public?
Can these strategies help improve timely diagnosis and management of DCM?
Raising awareness
2 What is the natural history of DCM? What is the relationship between DCM and asymptomatic spinal cord
compression or canal stenosis? What factors influence the natural history of the disease?
Natural history
3 What are the diagnostic criteria of DCM? When should imaging be used in the assessment of DCM? Diagnostic criteria
4 How can the severity of DCM be evaluated? What assessment tools can be used to evaluate functional impairment,
disability and quality of life in people with DCM?What instruments, tools or methods can be used or developed to
monitor people with DCM for disease progression or improvement either before or after surgical treatment? Is
there a role for smart technology?
Assessment and monitoring
5 What is the pathophysiology of DCM? What are the mechanisms of neurological injury and the molecular and
anatomical consequences?
Pathophysiology
6 What is the role of non-operative or peri-operative management or rehabilitation for DCM? What are the most
effective strategies?
Rehabilitation
7 Can novel therapies, including stem-cell, gene, pharmacological and neuroprotective therapies, improve the health
and wellbeing of people living with DCM and slow down disease progression?
Novel therapies
8 What is the socio-economic impact of DCM (the financial impact of living with DCM to the individual, their
supporters and society as a whole)?
Socio-economic impact
9 What is the role of dynamic imaging and novel, unconventional or advanced techniques in the assessment of DCM? Imaging techniques
10 Are there clinical and imaging factors that can help a surgeon select who should undergo surgical decompression in
the setting of DCM? At what stage of the disease is surgery the preferred management strategy?
Individualising/staging of
surgery
11 What are the main signs and symptoms that people with DCM present with? What are the frequency, sensitivity,
specificity and positive predictive value of symptoms and signs (clinical assessments) for DCM?
Signs and symptoms
12 What is the optimal follow-up for people with DCMmanaged conservatively and surgically?What is the appropriate
follow-up for people with DCM or those with spinal cord compression but no myelopathy? Who should follow
these individuals? How often should new imaging be obtained? How should changes in neurological status be
documented or addressed?
Follow-up
13 What are the most effective therapies for treatment of specific symptoms of DCM and the prevention of associated
complications in DCM, including spasticity, imbalance and sensory, bladder or bowel dysfunction?
Symptom management
14 What are the factors that predict the development of myelopathy in people with evidence of spinal cord compression
and no symptoms?
Predictors of development
15 What are the most important determinants of functional outcomes, quality of life and patient satisfaction following
surgical or non-operative treatment for DCM?
Predictors of outcome, QoL, and
satisfaction
16 What clinical and/or imaging features are predictive of neurological deterioration in people with DCM? Are there
certain features that indicate irreversible disease?
Predictors of progression
17 What are the risk factors for the development or progression of DCM, including but not limited to lifestyle, diet,




18 What is the ideal timing for surgical intervention? Timing of surgery
19 What is the efficacy and safety of non-operative treatment in the management of DCM compared with surgical
treatment? Can non-operative treatment avoid the need for surgery long-term? When can a ‘watch and wait’
approach be adopted?
Non-operative treatment
20 What are the most effective therapies for treating pain in people with DCM? Pain management
21 What is the preferred management strategy for people with mild DCM?What is the most cost-effective management
strategy in this cohort? Are there clinical and imaging features that predict who should undergo surgical decom-
pression and/or when?
Management of mild DCM
22 Can cerebrospinal fluid (CSF) or serum biomarkers be identified to support early diagnosis of DCM, and/or predict
treatment outcomes?
Biomarkers
23 What lifestyle modifications (such as physical activity or exercise) are required or should be recommended to people
with DCM to support recovery, avoid deterioration and improve quality of life?
Lifestyle modifications
24 What is the role of surgery in the management of people with imaging evidence of cord compression but no specific




25 What treatments should be implemented following surgery and continued in the long-term? Is there a role for
extended rehabilitation and exercise programmes?What should be its frequency, content and duration, and whom
should it be coordinated by?
Post-operative treatment
26 What is the incidence of adjacent segment degeneration following surgery for DCM? Are there strategies that can
reduce the incidence of adjacent segment degeneration?
Adjacent segment degeneration
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and emerging research activity aligns with the newly identi-
fied research priorities.
Methods
Primary clinical trials contained within the Myelopathy.org
Literature Database on DCM were evaluated for alignment
with the research priorities included in the final face-to-face
consensus meeting.
Myelopathy.org literature database
Systematic review and meta-analysis, otherwise known as re-
search synthesis, are important tools to quantitatively summa-
rise current knowledge about a topic. Their findings are fun-
damentally underpinned on the studies that they identify.
Within the field of DCM, there is inconsistent disease termi-
nology, with an absence of index terms or codes [7], which
makes literature searching extremely inefficient. For this rea-
son, and to support work by the Myelopathy.org charity, a
hand indexed database of primary clinical articles has been
maintained.
The dataset was built using a search of Embase and
MEDLINE for [“Cervical”] AND [“Myelopathy”]. It includes
primary clinical human trials, in which DCM is the primary
condition being addressed, with the full text available in
English. Animal studies, case reports, letters, editorials, re-
views, technical notes, commentaries, proposals and correc-
tions were excluded.
The database was initially built on previous systematic re-
views [2, 3] and initially contained all papers published up to
December 31, 2015 [8]. The last update was performed on
August 08, 2020. This updated database forms the basis of
this study.
Analysis
Each paper was assessed (by authors BG, HB, FB, RD, MK,
CIPS, JQT) for alignment to the established research priori-
ties. Each paper was allocated to one or more priorities, or
deemed to be not aligned to any priority.
The following information was extracted for each paper:
title, abstract, author names, country of corresponding author,
year of publication, research theme (as per [8]), patient char-
acteristics (number of patients, surgical vs. non-surgical treat-
ment) and study design (prospective or retrospective, cohort
or case-control, level of evidence).
Statistical analysis was used to detect differences in re-
search activity between research priorities and over time.
SPSS Statistics (IBM Corporation, Armonk, NY) was used
for all calculations. Shapiro-Wilk tests were used to analyse
normality of data, and parametric or non-parametric tests
were used accordingly. Significance was set at p < .05. We
report mean ± standard deviation unless otherwise
specified.
Results
Summary of global dataset
In total, 2261 papers, with a total of 1,323,979 patients (me-
dian, 63 patients in the 2230 articles that reported an N), were
included. Japan has published more papers (625, 27.6% of








Fig. 1 Global distribution of DCM research activity. Country colour indicates number of papers published in that country, as per the legend. The country
attributed is that of the lead author
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greatest number of patients (4,549,916). The aggregate global
distribution of research activity is shown in Fig. 1 and per
priority in Supplementary Data 3. Moreover, 727 (32.2%)
papers reported a prospective design, whilst 806 (35.6%) stud-
ies reported a retrospective design. Furthermore, 728 (32.2%)
papers had an unreported/unclear design.
Aggregate data per priority
Summary data for each priority are shown in Table 2. A sub-
stantial proportion (256/2261, 11.3%) of papers were not
aligned to any priority. Those papers assigned to a priority
were unevenly distributed. For instance, 1060/2261 (47%) of
papers were assigned to priority #15 (predictors of outcome
after treatment), whilst there were nine priorities that had few-
er than 10 papers each (Table 3).
Median sample sizes for each priority are shown in Fig. 2.
There was a statistically significant difference in the distribu-
tion of sample sizes between priorities (p = <0.001,
independent-samples Kruskal-Wallis test).
Research trends
The research activity in DCM over time is shown in Fig. 3 and
Supplementary Data 2. Growth of research activity in the dif-
ferent priorities is significantly different (p = <0.001, Pearson
Chi-squared test). For example, one priority (#21, manage-
ment of mild DCM) had no papers published in the past 5
years, whilst another priority (#13, symptom management)
Table 2 Aggregate data for each
priority Priority # N Mean Median Std. deviation Minimum Maximum % of total N
/ 249 429.91 60.00 3656.988 4 55,346 11.2%
1 7 88.86 89.00 64.955 8 187 0.3%
2 45 23,191.29 127.00 111,044.621 4 714,654 2.0%
3 26 81.08 58.50 64.974 12 244 1.2%
4 298 1269.14 66.00 18,700.061 3 322,869 13.4%
5 66 79.62 48.50 105.231 5 743 3.0%
6 8 6848.25 49.00 19,220.342 9 54,416 0.4%
7 26 90.38 42.50 92.078 5 280 1.2%
8 18 5212.39 187.50 12,602.700 36 50,605 0.8%
9 178 1501.21 63.00 10,118.974 5 109,728 8.0%
10 49 4162.00 88.00 20,637.732 6 141,450 2.2%
11 33 5969.91 109.00 33,041.216 4 190,021 1.5%
12 13 751.31 54.00 2500.028 3 9071 0.6%
13 3 47.67 36.00 34.990 20 87 0.1%
14 12 75.75 65.00 45.965 17 156 0.5%
15 1046 2519.87 64.50 42,632.284 2 1,323,979 46.9%
16 21 2810.43 42.00 12,490.841 8 57,323 0.9%
17 29 87.86 44.00 168.768 7 916 1.3%
18 7 273.14 208.00 235.099 110 778 0.3%
19 15 1139.80 79.00 4046.535 14 15,761 0.7%
20 9 38.78 39.00 19.156 8 73 0.4%
21 3 69.00 47.00 40.731 44 116 0.1%
22 35 130.37 45.00 208.829 1 1009 1.6%
23 3 46,530.33 587.00 79,901.167 212 138,792 0.1%
24 4 77.00 67.50 63.577 11 162 0.2%
25 7 127.71 45.00 170.041 8 481 0.3%
26 20 269.70 54.50 708.927 12 3209 0.9%
Total 2230 2346.73 63.00 34,630.011 1 1,323,979 100.0%
N number of papers,Meanmean number of patients per paper,Medianmedian number of patients per paper. Std.
Deviation is the standard deviation of N within each priority.Maximum and minimum refer to number of patients
in each paper.% of total N shows the percentage of all patients in each priority. The total number of papers shown
here (2230) is less than total number of papers in the database (2261) because not all papers have an N (i.e. not all
papers reported the number of patients)
1564 Acta Neurochir (2021) 163:1561–1568
had 33% of all its papers published in the past 5 years. Within
the last 5 years, three priorities have shown consistent growth
– #4 (assessment and monitoring), #9 (imaging techniques)
and #15 (predictors of outcome after treatment).
Discussion
Research activity in DCM continues to grow, and whilst a
number of priorities appear to be an increasing focus for re-
searchers, the majority of published research is not aligned
with the newly established research priorities with many pri-
orities showing little aligned activity.
Research activity in DCM continues to grow
This study was based on 2261 papers that form the entire
literature in DCM over the past 25 years – a relatively small
research output compared to other diseases of similar preva-
lence. Despite this, research activity has continued to grow
since our last evaluation [8], with 968 new papers since
January 1, 2016. In line with our previous findings, the
focus of DCM research remains on surgery. In particular,
the determinants of outcome after surgery (aligned with
Priority #15) have been a particular focus. These determi-
nants may include the choice and timing of the surgical
procedure [6, 11, 12].
Research activity in DCM does not align with newly
established research priorities
With the exception of Priority #15 (determinants of post-
treatment outcome), the established research priorities have
been under-represented. We found more papers not aligned
to any research priority (‘/’, 256 papers) than aligned to any
individual priority other than #15 and #4 (Table 3). This is
emphasised when examining the most important priorities –
the #1 priority (raising awareness) has only eight papers
aligned to it, and the top ten priorities have only 780 papers
between them, less than 35% of the 2261 included papers.
Furthermore, there is inequality in research activity amongst
the research priorities – both in cumulative counts (Tables 2
and 3) and in recent growth (Fig. 3).
It should be acknowledged that these priorities are newly
established and reflect on-going clinical uncertainties. The
literature included in this review spans 25 years, during
which time the research priorities may have been different.
For example, it is notable that during this period the evi-
dence base for surgical management has increased signifi-
cantly (as reflected within the AO Spine Guidelines [5]),
which is in line with substantial research activity [8]. These
findings therefore do not dismiss previous research but aim
to highlight the present directions and knowledge transla-
tion gap. However, this example does highlight the logical
correlation between a research focus and clinical progress,
substantiating within DCM the premise and potential for
research priority setting [1].
Role of this paper
This paper therefore serves several roles. Firstly, it acts as a
collection of research papers, comprising the entire current
DCM literature, to serve as a reference for current research.
Secondly, it indicates the magnitude of change required to
address the research priorities, indicating which priorities in
particular are under-researched. Both the established order
of importance and the existing number of papers aligned to
each priority may be used to guide researchers in choosing a
topic for research. Thirdly, it acts as a baseline, against
which the success of the AO Spine RECODE-DCM
Table 3 Number of papers per priority. This table shows all papers in
this study, including those that did not report an N (unlike Table 2)
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project, and in particular its KT strategy, may be measured
against in the future.
Limitations
As we have published previously [7], owing to the difficulties
in indexing DCM literature, the results presented here are
based upon an extensive hand search of the literature (title
and abstract only). Whilst this may introduce an element of
subjectivity – the reviewers must decide which papers meet
the pre-established criteria and which do not and this is not
always clear – this was the preferred approach to ensure a
more comprehensive representation of the field. Given this
breadth and the number of studies captured, we are confident
Fig. 2 Median paper sample size by priority. Note the logarithmic scale on the vertical axis. Error bars indicate 95% confidence intervals
Fig. 3 Cumulative number of
papers by priority. Cumulative
counts for each priority are shown
in different colours. Note that the
data for 2020 is up until February
12, and hence, the expected end-
of-year counts will likely be
higher
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that the overall findings are a true reflection of the DCM
research field, although we note the need for reproducibility
of methods in future research of this type. Establishing a clear
set of disease codes to combat this problem is one of the aims
of the AO Spine RECODE-DCM project and will help to
address this for the future.
Conclusion
Previous and emerging DCM research does not align with the
newly established research priorities. This poses a challenge
for the uptake and implementation of the research priorities.
However, the strong correlation between surgical research ac-
tivity over the last 25 years and the advances for its evidence
indicate that if this can be achieved it will pay dividends.
Supplementary Information The online version contains supplementary
material available at https://doi.org/10.1007/s00701-021-04767-6.
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